Developments in the Chemical Synthesis of Heparin and Heparan Sulfate
Authors:
Open Access
- 15 September 2021
- journal article
- research article
- Published by Wiley in The Chemical Record
- Vol. 21 (11) , 3238-3255
Abstract
Heparin and heparan sulfate represent key members of the glycosaminoglycan family of carbohydrates and underpin considerable repertoires of biological importance. As such, their efficiency of synthesis represents a key requirement, to further understand and exploit the H/HS structure‐to‐biological function axis. In this review we focus on chemical approaches to and methodology improvements for the synthesis of these essential sugars (from 2015 onwards). We first consider advances in accessing the heparin‐derived pentasaccharide anticoagulant fondaparinux. This is followed by heparan sulfate targets, including key building block synthesis, oligosaccharide construction and chemical sulfation techniques. We end with a consideration of technological improvements to traditional, solution‐phase synthesis approaches that are increasingly being utilised.Keywords
Funding Information
- Engineering and Physical Sciences Research Council (EP/T007397/1)
- UK Research and Innovation (MR/T019522/1)
- Keele University
This publication has 56 references indexed in Scilit:
- First Gram-Scale Synthesis of a Heparin-Related DodecasaccharideOrganic Letters, 2012
- Synthesis and Scalable Conversion of l-Iduronamides to Heparin-Related Di- and TetrasaccharidesThe Journal of Organic Chemistry, 2012
- Glycosaminoglycans: key players in cancer cell biology and treatmentThe FEBS Journal, 2012
- Modular Synthesis of Heparan Sulfate Oligosaccharides for Structure−Activity Relationship StudiesJournal of the American Chemical Society, 2009
- A synthetic CD4–heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entryNature Chemical Biology, 2009
- “Super Armed” Glycosyl Donors: Conformational Arming of Thioglycosides by SilylationJournal of the American Chemical Society, 2007
- Ein synthetisches Antithrombin III bindendes Pentasaccharid ist jetzt ein Wirkstoff! Was kommt danach?Angewandte Chemie, 2004
- A Synthetic Antithrombin III Binding Pentasaccharide Is Now a Drug! What Comes Next?Angewandte Chemie International Edition, 2004
- Heparan sulphate in the binding and activation of basic fibroblast growth factorGlycobiology, 1992
- Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans.Journal of Cell Biology, 1992